AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2690-4861/150
*Corresponding Author: Pooja Pithadia, Medical Biotechnology, Medica Pain Management Clinic, London, UK.
Citation: P Pithadia, S Tulpuele, M Rahman, M Singh. (2021) BMAC and Adipose-Derived MSCs Treatment for Knee Osteoarthritis: A Systematic Review. International Journal of Clinical Case Reports and Reviews. 7(5); DOI: 10.31579/2690-4861/150
Copyright: © 2021 Pooja Pithadia, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 18 June 2021 | Accepted: 14 July 2021 | Published: 17 July 2021
Keywords: bmac; stromal vascular fraction; adipose-derived mesenchymal stem cells; bone marrow aspirate concentrate; svf; knee osteoarthritis
Background: Knee osteoarthritis is the most common musculoskeletal progressive disorder that affects nearly 303 million people worldwide. This condition prevails in 10% males and 13% females among the elders above 60. Although there is conventional nonsurgical and surgical treatment available for knee osteoarthritis, there is a fascinating interest in bone marrow aspirate concentrate (BMAC) as well as adipose-derived mesenchymal stem cells (AD-MSC), including enzymatically treated stromal vascular fraction (SVF) and mechanically treated (microfat/nanofat) injections among physicians. Hence, this systematic review aims to determine the efficacy of BMAC and AD-MSCs (enzyme and mechanically treated) injections for knee osteoarthritis treatment.
Methods: A systematic review was performed on the following data sources (PubMed, Scopus, Google Scholar, EMBASE, and Cochrane Library) published on March 31, 2021. The keywords or MeSH terms include 'Knee Osteoarthritis with 'Bone marrow aspirate concentrate' OR 'BMAC' or with 'Adipose-derived mesenchymal stem cells (AD-MSC)' or with 'Stromal vascular fraction' OR 'SVF' or 'Mechanically treated AD-MSC (mfat/nanofat)'. In addition, the retrieved articles were further reviewed to identify relevant research studies.
Results: The authors reviewed and tabulated data based on the year of study, study type, therapy protocol, patient population, outcome measures, and interpretation. Among the 382 records screened, 43 studies (16 on BMAC and 27 on AD-MSCs) were included in the systematic review study. Among them, only 5 were randomized controlled trials. These selected studies demonstrated short-term positive outcomes such as improvement in knee pain and function with no adverse side effects. Moreover, researchers reported varied administration methods of BMAC or AD-MSC either as standalone or in combination with other conservative procedures such as PRP (Platelets Rich Plasma), HA (Hyaluronic acid), or surgery.
Conclusions: BMAC and AD-MSC (enzymatically and mechanically treated) injections prove safer and more efficacious in patients with knee osteoarthritis for a shorter duration of 2 years. However, the available literature lacks high-quality studies with no varied clinical settings and long-term follow-up of more than two years.
Osteoarthritis (OA) is the most common type of progressive musculoskeletal arthritic disorder affecting nearly 303 million people worldwide [1]. Compared to all the joint regions, OA commonly affects hip and knee joints [2]. Due to a steady increase in ageing, obesity, and life expectancy, knee OA is prevalent in 10% males and 13
This systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [17,18].
A comprehensive, systematic literature search was performed in April 2021, and an analysis of these articles was conducted by all the authors involved in the study. The databases of PubMed, Scopus, Google Scholar, EMBASE, and Cochrane Library were searched from 2011 to March 31, 2021. The following keywords were used in different combinations: 'Knee Osteoarthritis with 'Bone marrow aspirate concentrate' OR 'BMAC' or 'Adipose-derived mesenchymal stem cells or 'Stromal vascular fraction' OR 'SVF' or 'Mechanically treated AD-MSC (mfat/nanofat)'.
Study selection
All participants in the trials had to have a clinical diagnosis of knee osteoarthritis under either intra-articular BMAC or AD-MSCs treatment.
We limited the search to articles in English, and only human studies were included. After assessing all titles and abstracts, all relevant articles were obtained. Even the bibliographies were also searched to identify further relevant literature that met our inclusion criteria.
All studies were included if their design could be classified into one of the following categories: open-label, randomized controlled trial, prospective, retrospective study, and pilot study.
We included studies in which adult participants were diagnosed with knee osteoarthritis by clinical or image evaluation. We excluded articles lacking access to the full text, conference presentations, narrative reviews, editorials, and expert opinions.
The articles found were pooled and subjected to inclusion and exclusion criteria established before the commencement of this systematic review. A PRISMA flowchart of this systematic review is provided in Figure I.
Data extraction
The researchers independently recorded the study design, therapy protocol, patient population, outcome measures, and interpretations.
Literature search
Of the 382 articles initially identified by the search, 16 [19,30,32,35] on BMAC and 27 [36,62,16]. on AD-MSCs, including SVF, met the inclusion criteria. Therefore, the relevant data is given in Tables III and IV.
Participants
The 16 studies under BMAC involved 10 to 681 patients with the age group of between 18-85 affected by knee OA [Table I), while 27 studies under AD-MSCs, including SVF, involved 2 to 2586 knee OA patients between 18-89 age group [Table II]. Among these 44 studies, only 5 were randomized controlled trials. Fourteen papers were prospective studies, with three of them being comparative, two being open-label, one being a pilot study. The rest were retrospective studies, with two of them being comparative.
Therapeutic approaches
Regarding the therapeutic protocol, BMAC was either injected alone or combined with PRP in the same session, alternatively as a booster dose after a certain period. Very few authors injected BMAC in association with adipose tissue or scaffold. Under AD-MSCs, it was either injected alone or combined with PRP, adipose tissue, HA, or scaffold.
Outcome measures
Regarding outcomes, varied clinical scores such as WOMAC, VAS, KOOS, IKDC, KSS, ICOAP, NPS, and LEFS were used to evaluate the outcomes of BMAC injections (Table 1) and AD-MSCs injections (Table 2). Even MRI was performed before and after the procedure to detect positive changes in the resultant images. Very few authors used ICRS, OKS, NRS, ROM, Tegner activity, Lysholm patient satisfaction scores, and PROMIS questionnaires. Immunohistochemical analysis was reported only in Roato et al. 55. 's study involving AD-MSCs injections.
Safety and efficacy of BMAC and AD-MSCs therapy
None of the studies analyzed in this systematic review recorded any complication or adverse effect of BMAC and AD-MSCs administration. Only mild pain and swelling have been observed in very few patients within the initial few days following BMAC/AD-MSCs injection procedure. Furthermore, both BMAC and AD-MSCs showed positive clinical outcomes with significant improvement in pain, articular function, and range of movement.
The results of this systematic review validate that both BMAC and AD-MSCs treatments are safe and effective to treat knee OA. However, the therapeutic use of BMAC and AD-MSCs, especially SVF, is restricted across the United States, Europe, and many other countries based on safety and efficacy concerns.
The significant finding of this systematic review is that most of the studies are of low quality with a lack of well-defined methodologies, with very few RCTs, thus preventing us from providing any substantial conclusions on the therapeutic potential of these AD-MSCs and BMAC injections.
Furthermore, there is an inadequate patient selection process, although these studies reported good reliability. The inclusion and exclusion criteria, recruitment rate, and a well-defined selection process were rarely reported. Hence, further studies including larger patient cohorts should be performed to demonstrate the long-term effect of both BMAC and AD-MSCs injections.
Many patients underwent conservative treatments such as steroid treatment or surgical procedures in most of these studies, such as microfracture, arthroscopic debridement, or high tibial osteotomy. Hence there is no clear understanding of the exclusive clinical potential of these BMAC and AD-MSCs injections.
We can find the release of platelet-rich plasma (PRP) treatment without adequate evidence in the recent past. This treatment has been used clinically due to high media exposure only [61]. There is a possibility to exempt 510(k) regulations [62]. New medical devices "substantially equivalent" to those already prevalent in the market can skip the standard FDA approval process. Hence, there was an increase in the production of PRP kits. However, this market saturated due to overproduction by various preparation systems, thereby preventing a "standardization" of PRP therapy for knee OA treatment.
This same scenario is now approaching AD-MSCs and BMAC therapies that are not affected by the regulatory burden. Moreover, they can be quickly harvested from the OA patient and administered immediately through an intra-articular injection with PRP or HA (hyaluronic acid). HA provides an environment where MSCs can easily adhere to the target area around the lesion and differentiate into cells to build damaged bone and cartilage. Similarly, PRP consists of highly concentrated platelets and varied growth factors to exacerbate the proliferation of MSCs [68,69]. Hence, this simultaneous use of other biological agents or administering these treatments following the conventional procedures prevent a reasonable comparison of the studies performed so far.
The available RCTs have several biases since most of the patients were treated bilaterally [20,63]. This is not the ideal condition to determine the efficacy of a treatment since the patients cannot evaluate one knee independently from the other. There was no proper clarity on the number of cells administered and the exact number of injections for the best outcome. It was even difficult to interpret which one of the two treatments provide better outcomes. Although their immunophenotypes are more than 90% identical [64,65], they still have many distinct characteristics, especially in their cell surface markers, differentiation potentials, and distribution within the body. An in vitro analysis revealed that almost 300-fold more SVF can be derived from 100 g of adipose tissue when compared to 100 ml of bone marrow aspirate [66,67]. However, there is no apparent connection between the quantity and the dose-effect. Furthermore, there is no substantial evidence to define the patient's profile that could respond better to a specific treatment compared to others. Hence, this topic demands more research to understand the effect of both BMAC and AD-MSCs therapies.
Both bone marrow harvesting and lipoaspiration are minimally invasive procedures with minimal side effects. However, lipoaspiration was more severe due to the associated risks of pain and hematoma. Anyway, the surgeon who opts for these treatments depends on the availability of preparation kits in different countries. Moreover, industries have been releasing their proprietary kits for BMAC and AD-MSCs preparation, with new methods still being developed. However, there is no adequate research evidence to support the ability of MSCs.
At present, stem cell treatment is expensive and cannot be considered a "routine" treatment for knee cartilage degeneration. From a clinical viewpoint, the use of BMAC and AD-MSCs for knee OA treatment seems to be safe and deliver positive clinical outcomes. Moreover, this treatment can be a minimally invasive therapeutic option for patients who are ineligible for surgery. However, their promising outcomes for a shorter duration (3 months–24 months) must sustain for the long term of more than two years compared to the available conventional treatments. Hence, the use of BMAC or AD-MSCs therapies must be thoroughly discussed between the physician and the patient before proposing them as a first-line therapeutic approach to avoid surgery.
However, increasing the number of treatment options for knee OA does not always intend to improve the standard of care, especially when there is a lack of enough comparative trials that determine the effectiveness of a novel treatment compared to established ones.
Limitations
It is possible that BMAC and AD-MSCs injections could deliver positive outcomes in treating knee osteoarthritis, according to the results from our study. Nonetheless, the factors affecting the outcomes are but not limited to the lack of control group, a small number of studies and co-interventions, a small sample size, lack of long-term follow-up of not more than two years, the possibility of bias, and lack of objective assessment on the interventions
Although these above findings provide encouraging results, the lack of comparative study with corticosteroids and hyaluronic acid limits definitive conclusions, furthermore, the relationship of sex, age, and the severity of knee osteoarthritis could not be figured out clearly.
Additionally, MRI evaluation was not performed in all the studies to complement the clinical parameters, including the quantification of knee cartilage regeneration following the treatment. Moreover, there is a lack of comparison among the outcomes for different KL grades. Hence, more studies are required to confirm the positive long-term effects of AD-MSCs and BMAC therapies for knee osteoarthritis.
Despite having all these limitations, the treatment of knee osteoarthritis with BMAC and AD-MSCs seems to be safe by delivering positive clinical outcomes. This treatment can be a potential minimally invasive option for those who are ineligible for invasive approaches.
BMAC and AD-MSCs injections prove safer and more efficacious in treating knee osteoarthritis on a short-term duration (3 months-24 months) without any adverse side effects. However, only very few randomized control studies are published to support this result. Additionally, there is a lack of high-quality research studies for more than 2 years with varied trial settings.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
